Walki®Apron 45 has been certified and is now ready for delivery

Walki’s high-performance protective material for single use hospital aprons, Walki®Apron 45, has achieved the highest class according to the  standard based on the DIN EN 14126: 2004 norm.

The material  is now ready to be delivered to customers, who will make the aprons needed in hospitals all over the world in the fight against COVID-19.

The Walki®Apron 45 was certified to resist penetration by contaminated liquids under pressure and infective agents due to mechanical contact with substances containing contaminated liquids.

2020 04 23 202315

The material was also tested and certified for resistance to contaminated aerosols and solid particles.

“This means that the Walki®Apron 45 meets all the necessary safety standards, and the material is safe to use in protective gear for hospital personnel”, says Bart Vansteenkiste, Business Development Manager Engineered Materials at Walki.

The Walki®Apron 45 is based on a high-performance extrusion coated non-woven fabric suitable for medical applications.

The material used in hospital aprons needs to be highly tear-resistant to hinder the material from suffering damages during the manufacturing process. As hospital personnel work long days in difficult conditions, it is also important that the apron is comfortable to wear.

“The softness in the Walki®Apron makes it pleasant to wear”, says Vansteenkiste.

The first batches have been delivered to customers already and the feedback from hospital staff has been very positive.

Walki Group is a leading manufacturer of technical laminates and protective packaging materials specialising in the production of fibre-based, intelligent multi-laminate products for markets as diverse as energy-saving facings and construction membranes to barrier packaging applications. The Group has production facilities in Finland, Germany, the Netherlands, Belgium, Poland, the UK, Russia and China. The Group has a workforce of around 1100 people. In 2018, the Group’s annual turnover was EUR 317 million.